Mobile Menu

The Tri-Omics Summit USA

Front Line Genomics is pleased to announce the first Tri-Omics Summit in Boston, MA on 27th – 29th September 2022. The Tri-Omics Summit will address discuss three of the hottest areas within life sciences: single cell & spatial analysis, multi-omics and cancer genomics.

More than 50 speakers are confirmed to share their research and case studies including:

  • Baohong Zhang, Head of Research Data Sciences, Biogen
  • Jeffrey Moffitt, Assistant Professor, Harvard Medical School
  • Heidi Rehm, Chief Genomics Officer, Massachusetts General Hospital
  • J. Carl Barrett, VP, Translational Sciences Oncology, AstraZeneca
  • Kenna Mills Shaw, Executive Director, MD Anderson Cancer Center
  • Nikolaus Schultz, Computational Oncologist, Memorial Sloan Kettering Cancer Center
  • Stephen Bruce Baylin, Professor of Oncology, Johns Hopkins University
  • John Quackenbush, Chair, Department of Biostatistics, Harvard T.H. Chan School of Public Health
  • Sisi Chen, Director, Beckman Single cell Profiling and Engineering Center, Caltech

Here are just some of the organizations already confirmed to attend:

Harvard Medical School • Stanford University • The University of Texas MD Anderson Cancer Center • Memorial Sloan Kettering Cancer Center • Gilead • The University of Arkansas for Medical Sciences • Bayer • Scripps Research • Merck • Rutgers University • Sanofi • The Broad Institute • Duke University • Johns Hopkins University •  AstraZeneca • Caltech • Amgen • National Institutes of Health • GSK • UC San Diego • Bristol Myers Squibb • University of Toronto • Roche & more…

The Tri-Omics Summit brings you presentations and discussion across three different topics, so you’re no longer addressing important issues in a silo. With one ticket, you can access all the content from the three events across three days, switching between tracks whenever you like (without missing a thing).

Here’s a small selection of the talks that we thought may be of interest to you:

  • Network-based multi-omics integration and biomarker discovery
    – Jianguo (Jeff) Xia, Associate Professor, McGill University
  • Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
    – Stephanie Byrum, Associate Professor, University of Arkansas for Medical Sciences
  • Multi-omics analytical framework reveals sequential transcriptional waves and epigenetic plasticity that direct drug-induced dedifferentiation in cancer
    – Wei Wei, Andy Hill CARE Distinguished Researcher, Assistant Professor, Institute for Systems Biology
  • FAIR gene-disease data integration, annotation, and expression analysis with dynamic visualization for predictive and precision medicine
    – Zeeshan Ahmed, Assistant Professor, Rutgers University
  • Computational approaches to single cell sequencing: helping single cell data be its best self
    – Mathew Chamberlain, Senior Scientist, Janssen
  • Seq and you will find: Advancing innovative therapeutics through next generation sequencing technologies
    – Craig S. Mickanin, Executive Director, Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research
  • Constructing tissue atlases with MERFISH
    – Jeffrey Moffitt, Assistant Professor, Harvard Medical School, and Investigator of cellular molecular medicine, Boston Children’s Hospital
  • Profiling brain tumours with single-cell and spatial omics
    – Craig S. Mickanin, Executive Director, Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research
  • The genomic characterization of metastatic patterns from prospective clinical sequencing
    – Nikolaus Schultz, Professor, Computational Oncology, Memorial Sloan Kettering Cancer Center
  • Harnessing computational pathology for the next era of cancer drug targets
    – J. Carl Barrett, Vice President, Translational Science Oncology, AstraZeneca
  • Liquid Biopsy ctDNA for solid tumor MRD detection
    – Aadel Chaudhuri, Assistant Professor and Group Leader, Washington University School of Medicine
  • Precision prevention of invasive breast cancer
    – Aditi Hazra, Assistant Professor of Medicine, Harvard Medical School & Brigham and Women’s Children’s hospital

Tickets are free for the vast majority of the audience. And, if you can’t make the in-person event, a digital version takes place one week later!

For more details and information visit

More on these topics

Cancer / Multi-omics / Single cell / spatial omics